AAAAAA

   
Results: 1-9 |
Results: 9
PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA 16 YEARS AFTER THEAPPARENT CURE OF ACUTE LYMPHOBLASTIC-LEUKEMIA - NEW LEUKEMIA OR LATE RELAPSE
Authors: NAVARRO JL ORLANDO JD HERRANZ ER CAMPOS JG PARODY R FERNANDEZ JMR
Citation: Jl. Navarro et al., PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA 16 YEARS AFTER THEAPPARENT CURE OF ACUTE LYMPHOBLASTIC-LEUKEMIA - NEW LEUKEMIA OR LATE RELAPSE, Haematologica, 83(9), 1998, pp. 855-856
TRANSPLANTATION WITH PERIPHERAL-BLOOD STEM-CELLS FROM UNRELATED DONORIN CHRONIC MYELOCYTIC-LEUKEMIA
Authors: ESPIGADO I LENDINEZ F CARMONA M PARODY R DESOTO CP PRIETO J RIOS E FERNANDEZ JMR
Citation: I. Espigado et al., TRANSPLANTATION WITH PERIPHERAL-BLOOD STEM-CELLS FROM UNRELATED DONORIN CHRONIC MYELOCYTIC-LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 35-35
EARLY INFECTIONS IN 163 CONSECUTIVE AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTS
Authors: ESPIGADO I PARODY R CISNEROS JM CAMUNEZ JA DESOTO CP DELUIS J CARNICERO F LENDINEZ F RODRIGUEZ JM
Citation: I. Espigado et al., EARLY INFECTIONS IN 163 CONSECUTIVE AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTS, Bone marrow transplantation, 21, 1998, pp. 505-505
INTENSIVE CHEMOTHERAPY (CHT), ALLOGENEIC (ALLO) OR AUTOLOGOUS (AUTO) HEMATOPOIETIC-CELLS TRANSPLANTATION (HCT) FOR HIGH-RISK ALL (HRALL) - RESULTS OF THE ONGOING PROTOCOL PETHEMA ALL-93
Authors: RIBERA JM ORTEGA JJ ORIOL A FONTANILLAS M MALDONADO J PARODY R RIVAS C HERNANDEZRIVAS JM DELPOTRO E BASTIDA P GONZALEZ ME CALVO C RODRIGUEZ JM FELIU E SANMIGUEL JF
Citation: Jm. Ribera et al., INTENSIVE CHEMOTHERAPY (CHT), ALLOGENEIC (ALLO) OR AUTOLOGOUS (AUTO) HEMATOPOIETIC-CELLS TRANSPLANTATION (HCT) FOR HIGH-RISK ALL (HRALL) - RESULTS OF THE ONGOING PROTOCOL PETHEMA ALL-93, British Journal of Haematology, 102(1), 1998, pp. 316-316
COMPARISON OF INTENSIVE CHEMOTHERAPY (CHT), ALLOGENEIC (ALLO) OR AUTOLOGOUS (AUTO) HEMATOPOIETIC-CELLS TRANSPLANTATION (HCT) FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (HRALL) - PRELIMINARY-RESULTS OF THE ONGOING PROTOCOL PETHEMA ALL-93
Authors: RIBERA JM ORTEGA JJ ORIOL A FONTANILLAS M MALDONADO J PARODY R RIVAS C HERNANDEZRIVAS JM DELPOTRO E TEROL MJ BASTIDA P GONZALEZVALENTIN ME FELIU E GARCIACONDE J DIAZMEDIAVILLA J SANMIGUEL JF
Citation: Jm. Ribera et al., COMPARISON OF INTENSIVE CHEMOTHERAPY (CHT), ALLOGENEIC (ALLO) OR AUTOLOGOUS (AUTO) HEMATOPOIETIC-CELLS TRANSPLANTATION (HCT) FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (HRALL) - PRELIMINARY-RESULTS OF THE ONGOING PROTOCOL PETHEMA ALL-93, Blood, 90(10), 1997, pp. 998-998
REVERSAL OF SEVERE HEPATIC VENOOCCLUSIVE DISEASE BY COMBINED PLASMA-EXCHANGE AND RT-PA TREATMENT
Authors: ESPIGADO I RODRIGUEZ JM PARODY R CARMONA M DIGON J OLLOQUI E
Citation: I. Espigado et al., REVERSAL OF SEVERE HEPATIC VENOOCCLUSIVE DISEASE BY COMBINED PLASMA-EXCHANGE AND RT-PA TREATMENT, Bone marrow transplantation, 16(2), 1995, pp. 313-316
INTERFERON ALPHA-2A IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - RESULTS OF THE SPANISH GROUP
Authors: FERNANDEZRANADA JM LAVILLA E ODRIOZOLA J GARCIALARANA J LOZANO M PARODY R GIRALDO MP CARBONELL F FERRO MT STEEGMANN JL
Citation: Jm. Fernandezranada et al., INTERFERON ALPHA-2A IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - RESULTS OF THE SPANISH GROUP, Leukemia & lymphoma, 11, 1993, pp. 175-179
GENERATION OF LAK CELLS IN-VITRO IN PATIENTS WITH ACUTE-LEUKEMIA
Authors: PARRADO A RODRIGUEZFERNANDEZ JM CASARES S NOGUEROL P PLAZA E PARODY R ESPIGADO I DEBLAS JM GARCIASOLIS D
Citation: A. Parrado et al., GENERATION OF LAK CELLS IN-VITRO IN PATIENTS WITH ACUTE-LEUKEMIA, Leukemia, 7(9), 1993, pp. 1344-1348
TRANSLOCATION (812) IN A PATIENT WITH AGNOGENIC MYELOID METAPLASIA
Authors: BORREGO S ANTINOLO G MARTINNOYA A PARODY R
Citation: S. Borrego et al., TRANSLOCATION (812) IN A PATIENT WITH AGNOGENIC MYELOID METAPLASIA, Cancer genetics and cytogenetics, 71(2), 1993, pp. 183-184
Risultati: 1-9 |